Innovation is crucial to cardiovascular care transformation. MedAxiom connects cardiovascular leaders with industry innovators to accelerate critical products and services that improve clinical and operational outcomes.
Discover the latest cardiovascular solutions, news and resources from MedAxiom Industry Partners to take your program to the next level.
The latest MedAxiom Industry Partner announcements and news from industry innovators.
Published: Friday, February 6, 2026
Dedicated IT, a managed services provider with over two decades of experience serving healthcare organizations. This collaboration brings advanced IT support and strategic guidance to cardiovascular programs navigating increasingly complex technology demands.
Published: Tuesday, January 27, 2026
RhythMedix, a U.S.-based cardiac monitoring company with a fully integrated model that brings together device technology, manufacturing, software and 24/7, continuous clinical monitoring services.
Published: Monday, January 12, 2026
Novo Nordisk, Inc., a global healthcare leader committed to transforming the management of chronic diseases, including obesity, diabetes and cardiovascular conditions.
Published: Tuesday, December 16, 2025
Baker Donelson, one of the nation’s largest and most recognized healthcare law firms.
Published: Friday, October 31, 2025
The study, "AI-Guided Quantitative Plaque Evaluation from CT to Identify Patients with Future Myocardial Infarction or Death," analyzed 6,550 symptomatic patients (48% male, mean age 59) over 4.4 years who underwent coronary computed tomography angiography (CCTA) with AI-based quantitative coronary CT analysis (AI-QCT) across international sites.
Published: Wednesday, October 29, 2025
Kestra Medical Technologies, a wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using therapeutic intervention technologies that are intuitive, intelligent, and connected.
Published: Tuesday, October 21, 2025
These latest updates build on the AMA CPT Editorial Panel's February 2025 decision to approve new Category III CPT codes for CaRi-Heart technology.
Published: Tuesday, October 21, 2025
With this coverage breakthrough, more patients will benefit from Cleerly's ability to quantify and characterize coronary plaque noninvasively.
The MedAxiom Academy features webinars led by industry experts that educate and empower the entire cardiovascular care team to succeed in today's rapidly changing healthcare environment.
Explore breakthrough ideas and technologies advancing cardiovascular medicine.
From CV business white papers and data-driven reports to roadmaps for implementing new technologies, these publications arm you with the knowledge needed to transform cardiovascular care.
These publications were developed by MedAxiom with support from Industry Partners and are intended for informational purposes only. The statements and/or opinions expressed do not represent official American College of Cardiology (ACC) opinions, positions, policies or clinical guidance unless otherwise stated. These publications do not constitute a guarantee or endorsement of a specific product or therapy by MedAxiom or the ACC.
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.
_lrg.png)
_lrg.png)
.png)
_Pacemate_Co-Sponsor.PNG)
